SciELO - Scientific Electronic Library Online

 
vol.74 número1Infección respiratoria aguda baja por adenovirus en niños hospitalizados menores de dos años índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Links relacionados

Compartir


Archivos de Pediatría del Uruguay

versión On-line ISSN 1688-1249

Resumen

PIREZ, MARíA CATALINA et al. Neumonía bacteriana adquirida en la comunidad en niños hospitalizados. Arch. Pediatr. Urug. [online]. 2003, vol.74, n.1, pp.6-14. ISSN 1688-1249.

Introduction: bacterial pneumonia is a frequent cause of hospitalization in children. Treatment guidelines adapted to local epidemiology are being applied since 1997. Objective: describe clinical, radiologic and etiologic characteristics of children hospitalized with community-acquired bacterial pneumonia (CABP) and evaluate compliance and validity of antimicrobial treatment with penicillin and derivates (ampicillin, amoxicillin) and/or macrolides. Method: from 19th May, 1999 through 18th May, 2000 children from one month to 14 years old hospitalized at the Centro Hospitalario Pereira Rossell with CABP were studied. On admission chest radiography and blood culture were performed as well as pleural fluid study when indicated. Children were treated according to the above mentioned guidelines. Results: 697 children (7,7% of all patients discharged in the study period) were included. Children under five years were predominant. Chest radiography showed pulmonary consolidation in 95% of the cases. In 76 of 77 children S. pneumoniae was indentified. Pneumococcal serotypes 5, 14 and 1 were the most prevalent, the 4 penicillin resistant strains (CIM ³ 2 µg/ml) corresponded to serotype 14. Empyema was diagnosed in 16% of the children. Treatment guidlines were followed in 93% of the cases. Eight children died; in four of them S. pneumoniae was identified, none was penicillin-resistant. Conclusions: recommended treatment guidelines remain valid. Empyema risk factors should be investigated. In order to diminish morbidity and mortality due to pneumonia, improving prevention strategies at primary level and knowledge of S. pneumoniae serotypes in order to consider possible future vaccination, are required.

Palabras clave : PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; ANTIBIOTICS [therapeutic use].

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons